And so, one other working week will quickly draw to an in depth. Not a second too quickly, sure? That is, you might recall, our treasured sign to daydream about weekend plans. Our agenda is pretty modest. We hope to make amends for our studying, spend time with our Pharmalot ancestor, and promenade with the official mascots. We additionally hope to carry one other listening social gathering, the place the rotation will possible function this, this, this, this, and this. And what about you? This can be a grand time to benefit from the nice outside. Seashores and lakes are beckoning. Metropolis streets need to be strolled. And woods are inviting the adventurous for lengthy mysterious walks. Take your choose. Or you could possibly merely disguise indoors and binge-watch one thing on the telly. Effectively, no matter you do, have a grand time. However be secure. Take pleasure in, and see you quickly …
The U.S. Supreme Courtroom rejected a chapter deal during which the homeowners of Purdue Pharma sought to contribute as much as $6 billion in alternate for immunity from additional lawsuits, STAT studies. The ruling means the corporate and its collectors — together with quite a few state and native governments — should negotiate a brand new settlement. The 5-4 determination was a rebuke to members of the Sackler household, who management the corporate and demanded the authorized defend in return for contributing to the deal despite the fact that, as people, they didn’t file for chapter. The immunity was an enormous sticking level and prevented the deal, permitted by a chapter choose three years in the past, from being finalized.
A U.S. Home committee overwhelmingly handed 4 payments that might broaden Medicare protection of weight problems medicine and most cancers screening blood exams and place guardrails round Medicare’s discretion in overlaying medicine and units permitted by the Meals and Drug Administration, STAT writes. The Home Methods & Means Committee handed weight problems drug protection laws that might provide a restricted pathway for adults 65 and older to get their weight reduction medicine paid for by Medicare. Proper now, Medicare is prohibited from overlaying medicines used for weight reduction, like Wegovy and Zepbound.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and networking platform entry.
Have already got an account? Log in
Have already got an account? Log in
View All Plans